91 related articles for article (PubMed ID: 7932163)
1. Serotonin inhibits gastric acid secretion through a 5-hydroxytryptamine1-like receptor in the rat.
LePard KJ; Stephens RL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1139-44. PubMed ID: 7932163
[TBL] [Abstract][Full Text] [Related]
2. Role of 5-hydroxytryptamine (5-HT) in the mechanism of reserpine-induced stimulation of H+ output in the rat. A new hypothesis for the mechanism of gastric acid secretion.
Salim AS
Clin Physiol Biochem; 1992; 9(4):132-7. PubMed ID: 1302168
[TBL] [Abstract][Full Text] [Related]
3. Serotonin microinjected into the nucleus raphe obscurus increases intragastric pressure in the rat via a vagally mediated pathway.
Krowicki ZK; Hornby PJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):468-76. PubMed ID: 8097247
[TBL] [Abstract][Full Text] [Related]
4. Serotonin-induced increase in cAMP in ganglia isolated from the myenteric plexus of the guinea pig small intestine: mediation by a novel 5-HT receptor.
Fiorica-Howells E; Wade PR; Gershon MD
Synapse; 1993 Apr; 13(4):333-49. PubMed ID: 8386861
[TBL] [Abstract][Full Text] [Related]
5. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
[TBL] [Abstract][Full Text] [Related]
6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
9. Serotonin enhances gastric acid response to TRH analogue in dorsal vagal complex through 5-HT2 receptors in rats.
Yoneda M; Taché Y
Am J Physiol; 1995 Jul; 269(1 Pt 2):R1-6. PubMed ID: 7631881
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
Benloucif S; Keegan MJ; Galloway MP
J Pharmacol Exp Ther; 1993 Apr; 265(1):373-7. PubMed ID: 8474019
[TBL] [Abstract][Full Text] [Related]
12. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
13. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
14. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
16. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization.
Chapin EM; Andrade R
J Pharmacol Exp Ther; 2001 Apr; 297(1):395-402. PubMed ID: 11259568
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
Haddjeri N; de Montigny C; Blier P
Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
[TBL] [Abstract][Full Text] [Related]
18. Serotonin depletion potentiates gastric secretory and motor responses to vagal but not peripheral gastric stimulants.
Stephens RL; Garrick T; Weiner H; Taché Y
J Pharmacol Exp Ther; 1989 Nov; 251(2):524-30. PubMed ID: 2572692
[TBL] [Abstract][Full Text] [Related]
19. Some novel 5-hydroxytryptamine1A (5-HT1A) receptor agonists reduce gastric acid and pepsin secretion, reduce experimental gastric mucosal injury and enhance gastric mucus in rats.
Farré AJ; Colombo M; Alvarez I; Glavin GB
J Pharmacol Exp Ther; 1995 Feb; 272(2):832-7. PubMed ID: 7853201
[TBL] [Abstract][Full Text] [Related]
20. 5-CT or DOI augments TRH analog-induced gastric acid secretion at the dorsal vagal complex.
Varanasi S; Chi J; Stephens RL
Am J Physiol; 1997 Nov; 273(5):R1607-11. PubMed ID: 9374800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
